Condition: Acute Chest Pain · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.
This description comes directly from the study's public registry record.
Hao Sun, MD, PhD · 13584017821 · haosun_6@163.com
Always discuss trial participation with your own doctor first.
| Nanjing Drum Tower Hospital | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06949059